La TEP des tumeurs neuroendocrines de l’intestin grêle |
| |
Institution: | 1. Department of surgery, Amiens University hospital, Amiens, France;2. Surgery Department NYU Langone Health, New York, NY, United States of America |
| |
Abstract: | This article focuses on the indication and the choice of tracer for PET/CT in case of neuroendocrine tumours (NET) of the small intestine, which are the most common digestive NETs. PET/CT can be used to search for the primary NET in case of detection of a metastasis, for staging and determination of resectability, for restaging, for optimising and determining the efficacy of therapeutic modalities in extended or recurrent forms. Currently, three types of PET tracers are routinely used: FDG can be useful in the case of aggressive NET especially the duodenum and proximal jejunum, FDOPA is the best tracer in the case of NET of distal jejunum or of ileum, the labeled somatostatin analogues 68Ga in the case of well-differentiated NET from the duodenum or proximal jejunum, or irrespective of the location of primary NET if treatment with somatostatin analogue is intended, to confirm the overexpression of somatostatin receptors by lesions. |
| |
Keywords: | PET/CT Neuroendocrine tumour Gut Somatostatin analogue |
本文献已被 ScienceDirect 等数据库收录! |
|